Invivyd, Inc. (IVVD) Stock

Invivyd, Inc. (IVVD) is a Healthcare stock trading at $0.94 (as of 2026-06-18), with a market capitalization of $335.85M and a trailing P/E of -3.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

The provided sources describe Adagio Therapeutics, Inc. rather than Invivyd, Inc., and no authoritative SEC 10-K Business text for Invivyd was included. As a result, a factual description of Invivyd cannot be generated from the supplied information.

Valuation — source: SEC EDGAR (first-party)
Price	$0.94
Market Cap	$335.85M
P/E Ratio	-3.3
Price / Book	1.41
Price / Sales	5.12
DCF Value (model)	$-2.71
DCF Upside vs Price	-386.8%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$53.43M
Net Margin	-98.2%
Return on Equity	-38.2%
Current Ratio	6.47
Revenue Growth (YoY)	110.5%
EPS Growth (YoY)	-79.0%
FCF Growth (YoY)	-65.8%

Financial Health — source: SEC EDGAR
Altman Z-Score	0.16 (distress)

Valuation vs Sector & Industry
Stock P/E	-3.3
Sector P/E (Healthcare)	20.9
Industry P/E (Pharmaceutical Products)	17.0
vs Sector	-116.0%
vs Industry	-119.7%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	JANUS HENDERSON GROUP PLC ($42.86M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Pharmaceutical Products
CEO	William E. Duke Jr.
Employees	99
Country	US
IPO Date	2021-08-06

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.